Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)
CUSIP: 28036F105
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 109,183,673
- Total 13F shares
- 98,918,436
- Share change
- -2,948,553
- Total reported value
- $2,640,722,866
- Put/Call ratio
- 27%
- Price per share
- $26.70
- Number of holders
- 197
- Value change
- -$78,891,260
- Number of buys
- 102
- Number of sells
- 81
Quarterly Holders Quick Answers
What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28036F105:
Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
14%
|
15,021,721
|
$400,929,733 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.2%
|
8,909,091
|
$237,783,639 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.9%
|
6,393,567
|
$170,644,304 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.3%
|
5,840,059
|
$155,871,175 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
3/4/5
|
Company · 10%+ Owner |
5.1%
|
5,549,900
|
$148,126,831 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.2%
|
4,558,519
|
$121,615,621 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
4,516,063
|
$120,533,722 | — | 30 Sep 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.1%
|
3,406,534
|
$90,920,392 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.6%
|
2,832,867
|
$75,609,220 | — | 30 Sep 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.6%
|
2,789,172
|
$74,443,001 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.1%
|
2,330,294
|
$62,195,547 | — | 30 Sep 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.9%
|
2,112,984
|
$56,395,543 | — | 30 Sep 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.8%
|
1,958,310
|
$52,267,294 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,953,424
|
$52,136,887 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.6%
|
1,781,006
|
$47,535,050 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,685,115
|
$44,975,719 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,599,535
|
$42,698,606 | — | 30 Sep 2024 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
1.4%
|
1,553,661
|
$41,467,212 | — | 30 Sep 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.4%
|
1,481,146
|
$39,531,787 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.3%
|
1,428,929
|
$38,138,115 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
1,250,385
|
$33,372,776 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
1%
|
1,100,536
|
$29,373,306 | — | 30 Sep 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.92%
|
1,000,632
|
$26,706,868 | — | 30 Sep 2024 | |
| VR Adviser, LLC |
13F
|
Company |
0.92%
|
1,000,000
|
$26,690,000 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.9%
|
987,030
|
$26,343,831 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.86%
|
934,387
|
$24,938,811 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.84%
|
917,166
|
$24,479,161 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.67%
|
726,871
|
$19,396,991 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.6%
|
657,070
|
$17,537,198 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.6%
|
653,208
|
$17,434,111 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.53%
|
577,565
|
$15,415,210 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
575,880
|
$15,370,237 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.5%
|
545,546
|
$14,560,622 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
538,249
|
$14,365,866 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
527,839
|
$14,088,023 | — | 30 Sep 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.48%
|
522,500
|
$13,945,525 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
522,086
|
$13,934,475 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.47%
|
511,905
|
$13,662,744 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
482,225
|
$12,870,585 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.42%
|
455,348
|
$12,153,238 | — | 30 Sep 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.41%
|
450,000
|
$12,010,500 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
418,131
|
$11,159,916 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.37%
|
404,113
|
$10,785,776 | — | 30 Sep 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.35%
|
384,767
|
$10,269,431 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
308,051
|
$8,221,882 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.28%
|
307,842
|
$8,216,303 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.27%
|
294,624
|
$7,863,162 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.25%
|
270,406
|
$7,217,136 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
261,458
|
$6,978,314 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.24%
|
256,645
|
$6,849,855 | — | 30 Sep 2024 |
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q4 2024
As of 31 Dec 2024,
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,918,436 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., BAKER BROS. ADVISORS LP, Novo Holdings A/S, JANUS HENDERSON GROUP PLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, Cormorant Asset Management, LP, and PERCEPTIVE ADVISORS LLC.
This page lists
197
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
174
Q4 2024 holders
197
Holder diff
23
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.